Alpha Tau Medical (DRTS) Other Non-Current Liabilities (2020 - 2026)
Alpha Tau Medical (DRTS) posted Other Non-Current Liabilities of $5.4 million for Q4 2025, up 41.6% sequentially from $3.8 million in Q2 2025, and up 60.4% YoY from $3.3 million in Q4 2024.
Alpha Tau Medical (DRTS) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Other Non-Current Liabilities for 6 years, with the latest figure at $5.4 million in Q4 2025.
- Quarterly Other Non-Current Liabilities rose 60.4% year-over-year to $5.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.4 million (up 60.4% YoY) and the FY2025 annual result came in at $5.4 million, up 60.4% from the prior year.
- Other Non-Current Liabilities improved to $5.4 million in Q4 2025 per DRTS's latest filing, from $3.8 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $18.6 million in Q4 2021 and troughed at $977000.0 in Q4 2023.
- A 5-year average of $7.1 million and a median of $4.1 million in 2024 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2021 and 2022: Other Non-Current Liabilities surged 247.06% in 2021, then slumped 88.04% in 2022.
- Over 5 years, Other Non-Current Liabilities stood at $18.6 million in 2021, then plunged by 88.04% to $2.2 million in 2022, then plunged by 56.15% to $977000.0 in 2023, then surged by 241.66% to $3.3 million in 2024, then surged by 60.4% to $5.4 million in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $5.4 million, $3.8 million, and $3.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.54 Mn |
| Dec 31, 2025 | 5.35 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Dec 31, 2024 | 3.34 Mn |
| Jun 30, 2024 | 4.06 Mn |
| Dec 31, 2023 | 977,000.00 |
| Dec 31, 2022 | 2.23 Mn |
| Mar 31, 2022 | 16.91 Mn |
| Dec 31, 2021 | 18.62 Mn |
| Mar 31, 2021 | 8.46 Mn |
| Dec 31, 2020 | 5.37 Mn |